Increased consumption of a bacterial enzyme that is a common additive in processed foods might be related to the increased incidence of celiac disease.

The Celiac Disease Foundation Young Investigator Research Grant Award is a one- to three-year grant totaling up to $180,000. The purpose of the Award is to encourage exceptional investigators to pursue independent careers in celiac disease research.

If you're interested in advancing treatments for cross-contact, and you meet the qualifications below, you may be able to participate in a study located in Seattle, Washington and Dallas, Texas.

ImmusanT, Inc., has announced that its therapeutic vaccine candidate, Nexvax2, has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA).

Celiac Disease Foundation quoted in Healthline article covering the Nexvax2 therapeutic vaccine candidate.